|
 |
|
|
 |
PHARMANETICS CONTACTS:
John Funkhouser, President, CEO
Mike Riddle, Executive Vice President
or
James A. McGowan
Chief Financial Officer
(919) 582-2600
www.unispheremag.com
|
|
|
|
FOR IMMEDIATE RELEASE
July 16, 2002
PHARMANETICS TO BROADCAST ITS SECOND QUARTER CONFERENCE CALL LIVE ON THE INTERNET
Raleigh, NC (July 16, 2002) PharmaNetics, Inc. (Nasdaq/NM: PHAR), a leader in theranostic management specializing in managing the delivery of therapeutics affecting coagulation, announced today that it will provide an online Web simulcast of its second quarter 2002 earnings conference call on Tuesday, July 30, 2002. The Company's results for the second quarter ended June 30, 2002, will be released prior to the opening of the market on Tuesday, July 30, 2002.
The live broadcast of PharmaNetics' conference call will begin at 11:00 a.m. Eastern Time on July 30, 2002. A 48-hour online replay will be available approximately two hours following the conclusion of the live broadcast. A link to these events can be found on the Company's website at www.unispheremag.com or at www.companyboardroom.com.
PharmaNetics, Inc., a leading biotech company, conceived the term "theranostics", defining an emerging new field of medicine that enables physicians to therapeutically manage coagulation parameters of their patients in the treatment of angina, myocardial infarction (heart attack), stroke, and pulmonary and arterial emboli. The Company's proprietary diagnostic platform generates rapid feedback on blood clot formation and dissolution. The Company's technology platform is the primary driver of collaborations with a number of major pharmaceutical companies, including Aventis Pharmaceuticals, to develop theranostic tests for specific compounds and disease indications being targeted by these corporations.
|
|
|
|
|
|
|
|
|
|
| |